{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:41:31Z","timestamp":1767145291672,"version":"build-2238731810"},"reference-count":33,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejrad.2016.10.015","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T03:18:05Z","timestamp":1476847085000},"page":"2195-2199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography"],"prefix":"10.1016","volume":"85","author":[{"given":"Christoph","family":"Schabel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Horger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Kum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin D.","family":"Ioanoviciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Bier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejrad.2016.10.015_bib0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/1042819031000151860","article-title":"Discordant response or progression in patients with myeloma treated with thalidomide-based regimens","volume":"45","author":"Anagnostopoulos","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0015","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0020","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ajh.23258","article-title":"Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients","volume":"87","author":"Moulopoulos","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0025","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0030","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3109\/10428194.2015.1090572","article-title":"Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging","volume":"75","author":"Bhutani","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications","volume":"25","author":"Walker","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0040","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2214\/ajr.160.5.8470575","article-title":"MR appearance of multiple myeloma of the spine before and after treatment","volume":"160","author":"Rahmouni","year":"1993","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiol.09090629","article-title":"Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging","volume":"254","author":"Lin","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0050","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2214\/AJR.10.5979","article-title":"Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results","volume":"196","author":"Horger","year":"2011","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0055","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0060","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1258\/ar.2011.110199","article-title":"Modern imaging techniques during therapy in patients with multiple myeloma","volume":"52","author":"Horger","year":"2011","journal-title":"Acta Radiol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0065","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/cncr.22572","article-title":"The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma","volume":"109","author":"Horger","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0070","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3109\/10428194.2015.1129535","article-title":"Implemented myeloma management with whole-body low-dose CT scan: a real life experience","volume":"57","author":"Mangiacavalli","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0075","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1148\/radiology.209.3.9844655","article-title":"Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging","volume":"209","author":"Lecouvet","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0080","first-page":"999","article-title":"Multiple myeloma: 2014 update on diagnosis, risk-stratification, and management","volume":"89","author":"Vincent Rajkumar","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.2013.099358","article-title":"European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma","volume":"99","author":"Engelhardt","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0090","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00256-015-2131-7","article-title":"Improvement of diagnostic confidence for detection of multiple myeloma involvement of the ribs by a new CT software generating rib unfolded images: comparison with 5- and 1-mm axial images","volume":"44","author":"Homann","year":"2015","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0095","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/leu.2009.173","article-title":"Proteasome inhibitors in the treatment of multiple myeloma","volume":"23","author":"Shah","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4137\/CMO.S7764","article-title":"Efficacy of bortezomib as first-line treatment for patients with multiple myeloma","volume":"7","author":"Painuly","year":"2013","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0105","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood.V96.9.2943","article-title":"Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy","volume":"96","author":"Hideshima","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0115","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-04-019778","article-title":"Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1\/2 study","volume":"108","author":"Mateos","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12185-012-1215-6","article-title":"Is fluorine-18-fluorodeoxyglucose positron emission tomography useful in monitoring the response to treatment in patients with multiple myeloma?","volume":"96","author":"Caldarella","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0125","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1200\/JCO.2009.23.7172","article-title":"Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma","volume":"28","author":"Ladetto","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.critrevonc.2012.06.008","article-title":"Novel lenalidomide-based combinations for treatment of multiple myeloma","volume":"85","author":"Cives","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0135","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1182\/blood.V99.12.4525","article-title":"Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications","volume":"99","author":"Mitsiades","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1259\/bjr\/21850180","article-title":"Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters","volume":"81","author":"Horger","year":"2008","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0145","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1148\/rg.317115050","article-title":"Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0","volume":"31","author":"Chalian","year":"2011","journal-title":"Radiographics"},{"key":"10.1016\/j.ejrad.2016.10.015_bib0150","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2214\/AJR.05.0038","article-title":"CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure","volume":"186","author":"Zacharia","year":"2006","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0155","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1038\/bcj.2015.57","article-title":"Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma","volume":"5","author":"Nishida","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejrad.2016.10.015_bib0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2214\/AJR.15.15089","article-title":"Improved follow-up and response monitoring of thoracic cage involvement in multiple myeloma using a novel CT postprocessing software: the lessons we learned","volume":"206","author":"Bier","year":"2016","journal-title":"Am. J. Roentgenol."}],"updated-by":[{"DOI":"10.1016\/j.ejrad.2018.04.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16303205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X16303205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T15:30:04Z","timestamp":1601134204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X16303205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0720048X16303205"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.015","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}